Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dialysis01:27

Dialysis

247
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
247
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

363
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
363
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

324
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
324
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

123
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
123
Kidney Structure01:45

Kidney Structure

68.5K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
68.5K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

54
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
54

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emergency-Only Dialysis: A Compassionate, Practical Solution.

Nephrology nursing journal : journal of the American Nephrology Nurses' Association·2024
Same author

Intradialytic Hypoxemia in Chronic Hemodialysis Patients.

Blood purification·2016
Same author

The patient wants to stop dialysis: the latest evidence on how to respond.

Nephrology news & issues·2012
Same author

Getting nurses involved in sodium control.

Nephrology news & issues·2010
Same author

How to make the new Conditions for Coverage work in your dialysis clinic. Patient assessment.

Nephrology news & issues·2009

Related Experiment Video

Updated: May 24, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

433

End Stage Kidney Disease Treatment Options.

Rachael Buening1,2,3, Sheila Deziel4,5,6

  • 1Lead Nephrology Clinical Specialist, Dialyze Direct, Chicago, IL.

Nephrology Nursing Journal : Journal of the American Nephrology Nurses' Association
|March 4, 2025
PubMed
Summary
This summary is machine-generated.

Patients with end-stage kidney disease must choose a renal replacement therapy. Early, multidisciplinary discussions about treatment options like transplant, dialysis, and supportive care are crucial for informed decision-making.

Keywords:
chronic kidney diseasediabetesend stage kidney diseasehemodialysiskidney replacement therapytransplantationtreatment options

More Related Videos

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

23.5K
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

7.4K

Related Experiment Videos

Last Updated: May 24, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

433
5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

23.5K
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

7.4K

Area of Science:

  • Nephrology
  • Renal Medicine
  • Patient Care

Background:

  • Chronic kidney disease (CKD) progresses to end-stage kidney disease (ESKD).
  • ESKD necessitates renal replacement therapy for survival.
  • Patients face critical treatment decisions upon reaching ESKD.

Purpose of the Study:

  • To emphasize the importance of early patient-provider discussions regarding ESKD treatment options.
  • To highlight the need for a multidisciplinary team approach in managing ESKD.
  • To outline available treatment modalities for patients with kidney failure.

Main Methods:

  • This is a conceptual overview, not a research study.
  • Literature review of current ESKD treatment guidelines and patient management strategies.
  • Analysis of the components of effective patient-centered care in nephrology.

Main Results:

  • Timely initiation of treatment option discussions improves patient outcomes.
  • Multidisciplinary team involvement ensures comprehensive patient support.
  • A range of therapeutic options exist, including transplantation, dialysis, and conservative management.

Conclusions:

  • Early and comprehensive discussions about renal replacement therapies are vital for patients with progressing CKD.
  • Integrating the multidisciplinary team into the decision-making process enhances patient care.
  • Informed choices among transplant, peritoneal dialysis, hemodialysis, and supportive care empower patients facing kidney failure.